Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Twenty-Four Week, Multicenter, Double-Blind, Randomized, Placebo- Controlled, Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of Vasomotor Symptoms Associated With Menopause.

Next Previous
Search
Trial Profile

A Phase 3, Twenty-Four Week, Multicenter, Double-Blind, Randomized, Placebo- Controlled, Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of Vasomotor Symptoms Associated With Menopause.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Paroxetine (Primary)
  • Indications Hot flashes; Menopausal syndrome; Vasomotor symptoms
  • Focus Registrational; Therapeutic Use
  • Sponsors Noven Pharmaceuticals

    • Most Recent Events

    • 14 Oct 2014 A pooled analysis of the effects of paroxetine on body weight and sexual function has been published in Menopause, according to a Noven Pharmaceuticals media release.
    • 14 Oct 2014 Pooled analysis of the effects of paroxetine on body weight and sexual function reported in a Noven Pharmaceuticals media release.
    • 12 Oct 2013 Pooled analysis for the effect of paroxetine on body weight and sexual function presented at the 24th Annual Meeting of the North American Menopause Society.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top